TVM Capital Named 2008 German Private Equity Firm of the Year by Private Equity International

TVM Capital Named 2008 German Private Equity Firm of the Year by Private Equity International
TVM Capital has been named by Private Equity International as the 2008 German Private Equity Firm of the Year.
The 2008 Global Private Equity Awards were announced today by Private Equity International and are the result of more than 50,000 votes cast by global private equity professionals. “We are honored to receive this award,” said Dr. Helmut Schühsler, a managing partner of TVM Capital. “It validates the TVM Capital team’s efforts to support early and commercial-stage companies in the execution of their growth plans as true long-term strategic partners. For many years our focus has been on management, operational improvement and opportunities in international markets.”
In the last two years, TVM Capital has added an increased focus on commercial stage venture capital in Europe, as well as "Mittelstand" growth capital investments in entrepreneur led or family owned businesses in Germany, Austria and Switzerland to the traditional early- and late-stage venture activities the firm has historically maintained for more than 25 years in its two key investment sectors, life sciences and technology. With the more reasoned company valuations of the current economic crisis the firm believes these markets will continue to be ripe for the diversified international investing strategy of the firm.
TVM Capital
TVM Capital is a global venture firm with a 25 year operating track record. The investment focus of TVM Capital on financing technology and life sciences companies has led to specialized, focused teams and dedicated funds to serve the target markets best. TVM Capital provides emerging companies with access to science, management talent and capital in Europe and the Northeast US, as well as in other emerging markets like China, India and the Middle East.
The TVM Capital Life Sciences Practice with 820 million Euros ($1.26B USD) under management is one of the largest venture and growth investors in biotechnology and pharmaceuticals in Europe and the US, with a growing presence in Asia. The Life Sciences team builds on the expertise, experience, international approach and demonstrated success in more than 115 previous investments and almost 40 IPOs from our biotechnology and pharmaceutical portfolio of companies. The team combines long-standing international investment experience with pharmaceutical and biotech operating track records with extensive networks and knowledge regarding science, product discovery and development, manufacturing, marketing and distribution, international commercialization and finance. Twenty years of successful investing and value creation, in traditional early and late-stage venture as well as venture growth and growth capital, makes the TVM Capital Life Science Practice a unique partner for the needs of the biotechnology and pharmaceutical industry. Founded in 1983, TVM Capital is headquartered in Munich with offices in Boston and Dubai.